July 16, 2024 By Email Richard Bryce XXXXXXXXXXXXX XXXXXXXXXXXX RE: Transition Services Agreement and General ReleaseenGene Holdings Inc. • September 10th, 2024 • Biological products, (no disgnostic substances) • Massachusetts
This letter of agreement and general release (“Agreement”) confirms our mutual agreement regarding the terms and conditions of your separation from employment with enGene USA, Inc. (“enGene” or the “Company”) and transition to a strategic advisor. You and the Company agree as follows:
EMPLOYMENT AGREEMENT FOR DR. RAJ PRUTHIEmployment Agreement • September 10th, 2024 • enGene Holdings Inc. • Biological products, (no disgnostic substances) • Massachusetts
THIS EMPLOYMENT AGREEMENT (this “Agreement”) is entered into by and between enGene USA, Inc., its successors and assigns (the “Company”) and Dr. Raj Pruthi (the “Executive”) as of the date first written below.
ENGENE HOLDINGS INC. NONQUALIFIED STOCK OPTION GRANT AGREEMENTNonqualified Stock Option Grant Agreement • September 10th, 2024 • enGene Holdings Inc. • Biological products, (no disgnostic substances) • British Columbia
This NONQUALIFIED STOCK OPTION GRANT AGREEMENT (this “Agreement”), dated as of July 22, 2024 (the “Date of Grant”), is delivered by enGene Holdings Inc., a company organized under the laws of British Columbia, Canada (the “Company”) to Ronald Cooper (the “Participant”).
